サマリー

ヒトマイクロバイオーム治療薬の世界市場 2023-2027
ヒトマイクロバイオーム治療薬市場は、2022-2027年に7億3295万米ドルの成長が予測され、予測期間中のCAGRは30.11%で加速すると予測されます。この調査レポートは、ヒトマイクロバイオーム治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、ヒトマイクロバイオーム治療薬市場の堅調なパイプライン、健康障害に対する既存の治療法の副作用によって牽引されています。
Technavio社のヒトマイクロバイオーム治療薬市場は以下のように分類されます：
製品別
- プロバイオティクス
- プレバイオティクス
- 医療用食品
- 処方薬
用途別
- 消化器疾患
- 感染症
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のヒトマイクロバイオーム治療薬市場の成長を促進する主な理由の1つとして、新規治療薬開発のための産学連携の増加を挙げています。また、ヒトマイクロバイオーム治療薬への投資の増加や、ヒトマイクロバイオーム治療薬市場におけるパートナーシップの増加は、市場の大きな需要につながるでしょう。
このレポートはヒトマイクロバイオーム治療薬市場を調査し、以下の調査分野をカバーしています：
- ヒトマイクロバイオーム治療薬市場のサイジング
- ヒトマイクロバイオーム治療薬市場の予測
- ヒトマイクロバイオーム治療薬市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、4D pharma Plc、BiomX Inc、Eligo Bioscience、ENTEROME SA、Evelo Biosciences Inc、Evogene社、Ferring BV社、Finch Therapeutics Group Inc.社、Flightpath Biosciences社、Johnson and Johnson Services Inc.社、MaaT Pharma社、Microbiotica Ltd.社、OptiBiotix Health Plc社、PureTech Health Plc社、Second Genome Therapeutics社、Seres Therapeutics Inc.社、Synlogic Inc.社、武田薬品工業 Inc.Ltd.、YSOPIA Bioscience、Locus Biosciences Inc.また、ヒトマイクロバイオーム治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/human-microbiome-therapeutics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global human microbiome therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global human microbiome therapeutics market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Probiotics - Market size and forecast 2022-2027
o Exhibit 34: Chart on Probiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Probiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Probiotics - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Probiotics - Year-over-year growth 2022-2027 (%)
o 6.4 Prebiotics - Market size and forecast 2022-2027
o Exhibit 38: Chart on Prebiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Prebiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Prebiotics - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Prebiotics - Year-over-year growth 2022-2027 (%)
o 6.5 Medical foods - Market size and forecast 2022-2027
o Exhibit 42: Chart on Medical foods - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Medical foods - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Medical foods - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Medical foods - Year-over-year growth 2022-2027 (%)
o 6.6 Prescription drugs - Market size and forecast 2022-2027
o Exhibit 46: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Product
o Exhibit 50: Market opportunity by Product ($ million)
o Exhibit 51: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 52: Chart on Application - Market share 2022-2027 (%)
o Exhibit 53: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 54: Chart on Comparison by Application
o Exhibit 55: Data Table on Comparison by Application
o 7.3 Gastrointestinal disorders - Market size and forecast 2022-2027
o Exhibit 56: Chart on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
o 7.4 Infectious diseases - Market size and forecast 2022-2027
o Exhibit 60: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
o 7.5 Others - Market size and forecast 2022-2027
o Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Application
o Exhibit 68: Market opportunity by Application ($ million)
o Exhibit 69: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 France - Market size and forecast 2022-2027
o Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 4D pharma Plc
o Exhibit 119: 4D pharma Plc - Overview
o Exhibit 120: 4D pharma Plc - Product / Service
o Exhibit 121: 4D pharma Plc - Key offerings
o 12.4 BiomX Inc.
o Exhibit 122: BiomX Inc. - Overview
o Exhibit 123: BiomX Inc. - Product / Service
o Exhibit 124: BiomX Inc. - Key offerings
o 12.5 Eligo Bioscience
o Exhibit 125: Eligo Bioscience - Overview
o Exhibit 126: Eligo Bioscience - Product / Service
o Exhibit 127: Eligo Bioscience - Key offerings
o 12.6 ENTEROME SA
o Exhibit 128: ENTEROME SA - Overview
o Exhibit 129: ENTEROME SA - Product / Service
o Exhibit 130: ENTEROME SA - Key offerings
o 12.7 Evelo Biosciences Inc.
o Exhibit 131: Evelo Biosciences Inc. - Overview
o Exhibit 132: Evelo Biosciences Inc. - Product / Service
o Exhibit 133: Evelo Biosciences Inc. - Key offerings
o 12.8 Evogene Ltd.
o Exhibit 134: Evogene Ltd. - Overview
o Exhibit 135: Evogene Ltd. - Business segments
o Exhibit 136: Evogene Ltd. - Key offerings
o Exhibit 137: Evogene Ltd. - Segment focus
o 12.9 Ferring BV
o Exhibit 138: Ferring BV - Overview
o Exhibit 139: Ferring BV - Product / Service
o Exhibit 140: Ferring BV - Key offerings
o 12.10 Finch Therapeutics Group Inc.
o Exhibit 141: Finch Therapeutics Group Inc. - Overview
o Exhibit 142: Finch Therapeutics Group Inc. - Product / Service
o Exhibit 143: Finch Therapeutics Group Inc. - Key offerings
o 12.11 Johnson and Johnson Services Inc.
o Exhibit 144: Johnson and Johnson Services Inc. - Overview
o Exhibit 145: Johnson and Johnson Services Inc. - Business segments
o Exhibit 146: Johnson and Johnson Services Inc. - Key news
o Exhibit 147: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 148: Johnson and Johnson Services Inc. - Segment focus
o 12.12 OptiBiotix Health Plc
o Exhibit 149: OptiBiotix Health Plc - Overview
o Exhibit 150: OptiBiotix Health Plc - Product / Service
o Exhibit 151: OptiBiotix Health Plc - Key offerings
o 12.13 PureTech Health Plc
o Exhibit 152: PureTech Health Plc - Overview
o Exhibit 153: PureTech Health Plc - Business segments
o Exhibit 154: PureTech Health Plc - Key offerings
o Exhibit 155: PureTech Health Plc - Segment focus
o 12.14 Second Genome Therapeutics
o Exhibit 156: Second Genome Therapeutics - Overview
o Exhibit 157: Second Genome Therapeutics - Product / Service
o Exhibit 158: Second Genome Therapeutics - Key offerings
o 12.15 Seres Therapeutics Inc.
o Exhibit 159: Seres Therapeutics Inc. - Overview
o Exhibit 160: Seres Therapeutics Inc. - Product / Service
o Exhibit 161: Seres Therapeutics Inc. - Key offerings
o 12.16 Synlogic Inc.
o Exhibit 162: Synlogic Inc. - Overview
o Exhibit 163: Synlogic Inc. - Product / Service
o Exhibit 164: Synlogic Inc. - Key offerings
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global human microbiome therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Probiotics - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Probiotics - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Probiotics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Probiotics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Prebiotics - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Prebiotics - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Prebiotics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Prebiotics - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Medical foods - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Medical foods - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Medical foods - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Medical foods - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Product ($ million)
Exhibits51: Data Table on Market opportunity by Product ($ million)
Exhibits52: Chart on Application - Market share 2022-2027 (%)
Exhibits53: Data Table on Application - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Application
Exhibits55: Data Table on Comparison by Application
Exhibits56: Chart on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Application ($ million)
Exhibits69: Data Table on Market opportunity by Application ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: 4D pharma Plc - Overview
Exhibits120: 4D pharma Plc - Product / Service
Exhibits121: 4D pharma Plc - Key offerings
Exhibits122: BiomX Inc. - Overview
Exhibits123: BiomX Inc. - Product / Service
Exhibits124: BiomX Inc. - Key offerings
Exhibits125: Eligo Bioscience - Overview
Exhibits126: Eligo Bioscience - Product / Service
Exhibits127: Eligo Bioscience - Key offerings
Exhibits128: ENTEROME SA - Overview
Exhibits129: ENTEROME SA - Product / Service
Exhibits130: ENTEROME SA - Key offerings
Exhibits131: Evelo Biosciences Inc. - Overview
Exhibits132: Evelo Biosciences Inc. - Product / Service
Exhibits133: Evelo Biosciences Inc. - Key offerings
Exhibits134: Evogene Ltd. - Overview
Exhibits135: Evogene Ltd. - Business segments
Exhibits136: Evogene Ltd. - Key offerings
Exhibits137: Evogene Ltd. - Segment focus
Exhibits138: Ferring BV - Overview
Exhibits139: Ferring BV - Product / Service
Exhibits140: Ferring BV - Key offerings
Exhibits141: Finch Therapeutics Group Inc. - Overview
Exhibits142: Finch Therapeutics Group Inc. - Product / Service
Exhibits143: Finch Therapeutics Group Inc. - Key offerings
Exhibits144: Johnson and Johnson Services Inc. - Overview
Exhibits145: Johnson and Johnson Services Inc. - Business segments
Exhibits146: Johnson and Johnson Services Inc. - Key news
Exhibits147: Johnson and Johnson Services Inc. - Key offerings
Exhibits148: Johnson and Johnson Services Inc. - Segment focus
Exhibits149: OptiBiotix Health Plc - Overview
Exhibits150: OptiBiotix Health Plc - Product / Service
Exhibits151: OptiBiotix Health Plc - Key offerings
Exhibits152: PureTech Health Plc - Overview
Exhibits153: PureTech Health Plc - Business segments
Exhibits154: PureTech Health Plc - Key offerings
Exhibits155: PureTech Health Plc - Segment focus
Exhibits156: Second Genome Therapeutics - Overview
Exhibits157: Second Genome Therapeutics - Product / Service
Exhibits158: Second Genome Therapeutics - Key offerings
Exhibits159: Seres Therapeutics Inc. - Overview
Exhibits160: Seres Therapeutics Inc. - Product / Service
Exhibits161: Seres Therapeutics Inc. - Key offerings
Exhibits162: Synlogic Inc. - Overview
Exhibits163: Synlogic Inc. - Product / Service
Exhibits164: Synlogic Inc. - Key offerings
Exhibits165: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits166: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits167: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits168: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations